Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289794196> ?p ?o ?g. }
- W4289794196 endingPage "144" @default.
- W4289794196 startingPage "136" @default.
- W4289794196 abstract "Taxanes are one of the most effective chemotherapies (CT) in breast cancer (BC), but the efficacy of taxanes rechallenge in early metastatic relapse has been poorly studied in patients previously treated by taxanes in the (neo)adjuvant setting. Our study aimed to analyse the efficacy of taxane rechallenge in case of early metastatic relapse in a multicentre retrospective observational study compared with other chemotherapies.We analysed the French national ESME metastatic BC (MBC) database and selected HER2- MBC patients who received CT in first-line treatment for a metastatic relapse occurring 3-24 months after previous (neo)adjuvant taxanes treatment.Of 23,501 female patients with MBC in ESME, 1057 met the selection criteria. 58.4% received a taxane-based regimen (75.4% concomitant bevacizumab) and 41.6% received other CT. In hormone-receptor positive (HR+)/HER2- MBC, multivariate analysis showed no difference in OS between taxanes without bevacizumab compared to other CT (HZR = 1.3 [0.97; 1.74], but taxanes was significantly associated with worse PFS (HZR = 1.48 [1.14; 1.93]). In TNBC, taxanes without bevacizumab and carboplatin/gemcitabine were not superior to other CT for OS (HZR = 1.07 [0.79; 1.44] and HZR = 0.81 [0.58; 1.13], respectively), while for PFS, taxanes was inferior (HZR = 1.33 [1.06-1.67]) and carboplatin plus gemcitabine was superior to other CT (HZR = 0.63 [0.46; 0.87]). For both subtypes, the worse outcome observed with paclitaxel was no longer observed with the addition of bevacizumab.With the limitation of retrospective design, taxanes rechallenge in early metastatic relapse of BC may result in a worse PFS in TNBC and HR+/HER2- MBC, which was not observed with the addition of bevacizumab." @default.
- W4289794196 created "2022-08-04" @default.
- W4289794196 creator A5002381363 @default.
- W4289794196 creator A5006642161 @default.
- W4289794196 creator A5026699354 @default.
- W4289794196 creator A5027527568 @default.
- W4289794196 creator A5032686530 @default.
- W4289794196 creator A5035249331 @default.
- W4289794196 creator A5035439475 @default.
- W4289794196 creator A5041911544 @default.
- W4289794196 creator A5043665560 @default.
- W4289794196 creator A5044752757 @default.
- W4289794196 creator A5049369439 @default.
- W4289794196 creator A5056961294 @default.
- W4289794196 creator A5066230101 @default.
- W4289794196 creator A5067379430 @default.
- W4289794196 creator A5068016669 @default.
- W4289794196 creator A5069540694 @default.
- W4289794196 creator A5074932302 @default.
- W4289794196 creator A5079006574 @default.
- W4289794196 creator A5084631227 @default.
- W4289794196 creator A5085324944 @default.
- W4289794196 creator A5087401871 @default.
- W4289794196 creator A5090608495 @default.
- W4289794196 date "2022-10-01" @default.
- W4289794196 modified "2023-10-18" @default.
- W4289794196 title "Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study" @default.
- W4289794196 cites W1521716186 @default.
- W4289794196 cites W1971211622 @default.
- W4289794196 cites W1984119576 @default.
- W4289794196 cites W1994486322 @default.
- W4289794196 cites W2004163315 @default.
- W4289794196 cites W2011223682 @default.
- W4289794196 cites W2064087555 @default.
- W4289794196 cites W2075213874 @default.
- W4289794196 cites W2081371289 @default.
- W4289794196 cites W2095633632 @default.
- W4289794196 cites W2103563357 @default.
- W4289794196 cites W2122929031 @default.
- W4289794196 cites W2123528875 @default.
- W4289794196 cites W2126275851 @default.
- W4289794196 cites W2126324838 @default.
- W4289794196 cites W2128941584 @default.
- W4289794196 cites W2132448724 @default.
- W4289794196 cites W2141056749 @default.
- W4289794196 cites W2148206476 @default.
- W4289794196 cites W2167224460 @default.
- W4289794196 cites W2171611244 @default.
- W4289794196 cites W2434209561 @default.
- W4289794196 cites W2503449349 @default.
- W4289794196 cites W2552099557 @default.
- W4289794196 cites W2763875663 @default.
- W4289794196 cites W2889646458 @default.
- W4289794196 cites W2917655541 @default.
- W4289794196 cites W2948069739 @default.
- W4289794196 cites W2990398119 @default.
- W4289794196 cites W3105665551 @default.
- W4289794196 cites W3109853980 @default.
- W4289794196 cites W3175173749 @default.
- W4289794196 cites W4206666777 @default.
- W4289794196 doi "https://doi.org/10.1016/j.breast.2022.07.014" @default.
- W4289794196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35944353" @default.
- W4289794196 hasPublicationYear "2022" @default.
- W4289794196 type Work @default.
- W4289794196 citedByCount "1" @default.
- W4289794196 countsByYear W42897941962023 @default.
- W4289794196 crossrefType "journal-article" @default.
- W4289794196 hasAuthorship W4289794196A5002381363 @default.
- W4289794196 hasAuthorship W4289794196A5006642161 @default.
- W4289794196 hasAuthorship W4289794196A5026699354 @default.
- W4289794196 hasAuthorship W4289794196A5027527568 @default.
- W4289794196 hasAuthorship W4289794196A5032686530 @default.
- W4289794196 hasAuthorship W4289794196A5035249331 @default.
- W4289794196 hasAuthorship W4289794196A5035439475 @default.
- W4289794196 hasAuthorship W4289794196A5041911544 @default.
- W4289794196 hasAuthorship W4289794196A5043665560 @default.
- W4289794196 hasAuthorship W4289794196A5044752757 @default.
- W4289794196 hasAuthorship W4289794196A5049369439 @default.
- W4289794196 hasAuthorship W4289794196A5056961294 @default.
- W4289794196 hasAuthorship W4289794196A5066230101 @default.
- W4289794196 hasAuthorship W4289794196A5067379430 @default.
- W4289794196 hasAuthorship W4289794196A5068016669 @default.
- W4289794196 hasAuthorship W4289794196A5069540694 @default.
- W4289794196 hasAuthorship W4289794196A5074932302 @default.
- W4289794196 hasAuthorship W4289794196A5079006574 @default.
- W4289794196 hasAuthorship W4289794196A5084631227 @default.
- W4289794196 hasAuthorship W4289794196A5085324944 @default.
- W4289794196 hasAuthorship W4289794196A5087401871 @default.
- W4289794196 hasAuthorship W4289794196A5090608495 @default.
- W4289794196 hasBestOaLocation W42897941961 @default.
- W4289794196 hasConcept C121608353 @default.
- W4289794196 hasConcept C126322002 @default.
- W4289794196 hasConcept C143998085 @default.
- W4289794196 hasConcept C2775930923 @default.
- W4289794196 hasConcept C2776694085 @default.
- W4289794196 hasConcept C2777292972 @default.
- W4289794196 hasConcept C2777511904 @default.
- W4289794196 hasConcept C2777802072 @default.